Download RSS feed: News Articles / In the Media / Audio
Miles O’Brien of the PBS NewsHour reports on how scientists are developing cheaper and more efficient tests for Ebola, highlighting Prof. Lee Gehrke’s simple diagnostic kits. Gehrke explains that the test his team developed is “very simple, requires no refrigeration, no power, no special training.”
MIT researchers have developed a test that can accurately detect cancer in urine, reports Megan Scudellari for The Boston Globe. “Bacteria can grow in tumors as small as 1 millimeter, so the urine test has the potential to detect liver tumors — which tend to be small and dispersed — very early on, which would improve survival rates for patients,” Scudellari explains.
Professor Sangeeta Bhatia and her colleagues have successfully engineered bacteria that can be used to detect cancer and diabetes, writes Robert Service for Science. The researchers found that “while conventional imaging techniques struggle to detect liver tumors smaller than 1 square centimeter, this approach was able to flag tumors as small as 1 square millimeter.”
Los Angeles Times reporter Melissa Healy writes that researchers from MIT and the University of California, San Diego have successfully modified bacteria to detect cancer. “Their work is a key component of broader efforts to make the diagnosis and treatment of diseases such as cancer increasingly precise and targeted," writes Healy.
Researchers from MIT and the University of California, San Diego have genetically modified bacteria so that it can detect cancer, BBC News reports. The researchers hope that one day, “the general approach could one day be used to develop relatively cheap and easy to use home-testing kits for a range of diseases.”
MIT researchers have developed a non-invasive way to detect liver cancer using probiotics, reports Vijee Venkatraman for BetaBoston. The researchers found that they could “use bacteria as tumor scouts…and engineer them to emit a signal once they reached the mass and multiply.”
In a piece for The Huffington Post, Zeynep Ilyaz explains how Prof. Sangeeta Bhatia serves as an inspiration to her, citing her research advances in biotech and medicine, and her mentorship of women pursuing careers in STEM fields. “Dr. Bhatia is constantly looking for the next groundbreaking discovery in health, which makes her an excellent role model for girls and women,” Ilyaz writes.
Jane Wakefield reports for BBC News on a system developed by postdoctoral fellow Tal Danino in which bacteria are programmed to detect cancers in the liver. "It is a fascinating universe in our body and we can now program bacteria like we program computers,” Danino says.
MIT researchers have developed a test for Ebola and other fevers using gold nanoparticle sensors that quickly identify the pathegon, writes Andrea Timpano for Boston Magazine. “It is important to recognize that the United States needs to have strategies for surveillance that will identify dangerous viruses,” says Professor Lee Gehrke.
“A promising new diagnostic test from MIT looks like it could be a game changer for rapidly diagnosing several important infectious diseases within minutes,” writes Judy Stone for Forbes. The paper test developed by MIT researchers can diagnose Ebola, yellow fever and dengue fever.
MIT researchers have developed a new silver nanoparticle-based paper test that can quickly detect dengue, yellow fever and Ebola, reports Vicki Davison for Scientific American. In addition to the paper test, the researchers are also working on developing a mobile application to ease diagnosis.
Prof. Robert Langer speaks with Chris Baraniuk of New Scientist about winning the Queen Elizabeth Prize for Engineering and his career in biotechnology. “It’s going to be the entrepreneurs, the new professors, the young people who are willing to think outside the box and not necessarily go down a conventional path,” says Langer of the future of medicine.
Michelle Roberts reports for BBC News on a new, “smart insulin” being developed by MIT researchers that switches on when blood sugar rises. The engineered insulin could make it easier for those suffering from diabetes to manage the disease, Roberts explains.
Joseph Flaherty of Wired writes about “Flowers,” a print created by postdoctoral fellow Tal Danino and MIT visiting artist Vik Muniz to educate people about the importance of vaccinations. Danino hopes to be able to apply the technique developed for creating the print, which contains real cancer and virus cells, to control the behaviors of specific cells and bacteria.
Professor Robert Langer has won the Queen Elizabeth Prize for Engineering for his pioneering work with medical technologies, reports David Shukman for BBC News. Shukman notes that “as many as two billion people have in some way been touched by technologies devised and developed by him and his teams.”